← Back to all clusters

Cluster 151

9 diseases · 19 shared-gene connections
9 Diseases
6 Unique genes
0.372 Avg. similarity score
Amyloid neuropathy Most-connected disease (7 links)
Log in to save this analysis

Save This Analysis

Disease Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details · click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) · drag a node to pin it in place · scroll/pinch to zoom.

Member diseases (most connected first ‐ the cluster's core)

Top shared genes (genes linked to 2+ member diseases)

Gene ⇵ Member diseases ⇵ Linked diseases
APP 6 / 9 Abeta amyloidosis, Amyloid angiopathy, Amyloid neuropathy, cerebral amyloid angiopathy, app-related and 2 more
PSEN1 3 / 9 Acne inversa, Amyloid neuropathy, Early onset alzheimers disease with behavioral disturbance
NCSTN 2 / 9 Acne inversa, Pash syndrome
What do these columns mean?
Connections in cluster
How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
Significant partners
How many of those links are statistically significant (FDR q < 0.05).
Curated genes
Distinct curated genes linked to that disease in GeDiPNet.
Member diseases (Top shared genes)
How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
Overlap genes (x / y)
x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
Cluster gene count
Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
Fold enrichment
Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
P-value / FDR q-value
Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
Shared genes (Pairs within this cluster)
Number of curated genes the two diseases in that row have in common.
Similarity score (Pairs within this cluster)
Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.

Enriched Pathways (why this cluster is grouped, biologically)

Pathway ⇵ Source ⇵ Overlap genes ⇵ Fold enrichment ⇵ P-value ⇵ FDR q-value ⇵
Noncanonical activation of NOTCH3 Reactome 3 / 8 751× 3.88e-9 3.77e-7 ✓ sig.
Regulated proteolysis of p75NTR Reactome 3 / 11 546× 1.14e-8 9.79e-7 ✓ sig.
NRIF signals cell death from the nucleus Reactome 3 / 15 400× 3.15e-8 2.39e-6 ✓ sig.
NOTCH3 Activation and Transmission of Signal to the Nucleus Reactome 3 / 19 316× 6.69e-8 4.62e-6 ✓ sig.
Amyloid fiber formation Reactome 4 / 109 73.5× 9.50e-8 6.25e-6 ✓ sig.
Nuclear signaling by ERBB4 Reactome 3 / 24 250× 1.40e-7 8.74e-6 ✓ sig.
EPH-ephrin mediated repulsion of cells Reactome 3 / 50 120× 1.35e-6 6.32e-5 ✓ sig.
Constitutive Signaling by NOTCH1 PEST Domain Mutants Reactome 3 / 58 104× 2.12e-6 9.22e-5 ✓ sig.
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants Reactome 3 / 58 104× 2.12e-6 9.22e-5 ✓ sig.
Notch signaling pathway KEGG 3 / 62 96.9× 2.59e-6 1.10e-4 ✓ sig.
Alzheimer disease KEGG 4 / 388 20.6× 1.53e-5 4.78e-4 ✓ sig.
Pathways of neurodegeneration - multiple diseases KEGG 3 / 480 12.5× 1.16e-3 1.52e-2 ✓ sig.
Neutrophil degranulation Reactome 3 / 480 12.5× 1.16e-3 1.52e-2 ✓ sig.
PTK6 promotes HIF1A stabilization Reactome 1 / 6 334× 2.99e-3 3.07e-2 ✓ sig.
Advanced glycosylation endproduct receptor signaling Reactome 1 / 8 250× 3.99e-3 3.77e-2 ✓ sig.

Enriched GO Terms (Biological Process, a second line of biological evidence)

GO term ⇵ GO ID ⇵ Overlap genes ⇵ Fold enrichment ⇵ P-value ⇵ FDR q-value ⇵
Notch receptor processing GO:0007220 3 / 9 1,038× 1.54e-9 3.30e-7 ✓ sig.
amyloid-beta formation GO:0034205 3 / 10 934× 2.21e-9 4.50e-7 ✓ sig.
amyloid precursor protein metabolic process GO:0042982 3 / 12 779× 4.04e-9 7.71e-7 ✓ sig.
amyloid precursor protein catabolic process GO:0042987 3 / 14 667× 6.69e-9 1.21e-6 ✓ sig.
Notch signaling pathway GO:0007219 4 / 117 106× 2.17e-8 3.35e-6 ✓ sig.
membrane protein ectodomain proteolysis GO:0006509 3 / 27 346× 5.36e-8 7.19e-6 ✓ sig.
astrocyte activation involved in immune response GO:0002265 2 / 4 1,557× 5.15e-7 4.79e-5 ✓ sig.
positive regulation of amyloid fibril formation GO:1905908 2 / 5 1,246× 8.59e-7 7.32e-5 ✓ sig.
learning or memory GO:0007611 3 / 72 130× 1.09e-6 8.87e-5 ✓ sig.
cellular response to manganese ion GO:0071287 2 / 7 890× 1.80e-6 1.33e-4 ✓ sig.
protein processing GO:0016485 3 / 95 98.4× 2.52e-6 1.73e-4 ✓ sig.
positive regulation of tumor necrosis factor production GO:0032760 3 / 113 82.7× 4.25e-6 2.63e-4 ✓ sig.
amyloid-beta metabolic process GO:0050435 2 / 12 519× 5.66e-6 3.31e-4 ✓ sig.
neuron projection maintenance GO:1990535 2 / 13 479× 6.69e-6 3.78e-4 ✓ sig.
membrane protein intracellular domain proteolysis GO:0031293 2 / 14 445× 7.80e-6 4.29e-4 ✓ sig.

Pairs within this cluster, by significance

Disease A ⇵ Disease B ⇵ Similarity score ⇵ Shared genes ⇵ P-value ⇵ FDR q-value ⇵
Amyloid angiopathy Eye manifestations 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Eye manifestations Partial epilepsy with variable foci 0.500 1 6.49e-5 2.34e-4 ✓ sig.
cerebral amyloid angiopathy, app-related Eye manifestations 0.500 1 6.49e-5 2.34e-4 ✓ sig.
cerebral amyloid angiopathy, app-related Partial epilepsy with variable foci 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Amyloid angiopathy cerebral amyloid angiopathy, app-related 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Abeta amyloidosis Amyloid angiopathy 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Amyloid angiopathy Partial epilepsy with variable foci 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Abeta amyloidosis cerebral amyloid angiopathy, app-related 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Abeta amyloidosis Eye manifestations 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Abeta amyloidosis Partial epilepsy with variable foci 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Acne inversa Pash syndrome 0.250 1 1.95e-4 5.28e-4 ✓ sig.
Abeta amyloidosis Amyloid neuropathy 0.250 1 1.95e-4 5.28e-4 ✓ sig.
Amyloid angiopathy Amyloid neuropathy 0.250 1 1.95e-4 5.28e-4 ✓ sig.
Amyloid neuropathy Partial epilepsy with variable foci 0.250 1 1.95e-4 5.28e-4 ✓ sig.
Amyloid neuropathy Eye manifestations 0.250 1 1.95e-4 5.28e-4 ✓ sig.
Amyloid neuropathy cerebral amyloid angiopathy, app-related 0.250 1 1.95e-4 5.28e-4 ✓ sig.
Acne inversa Early onset alzheimers disease with behavioral disturbance 0.200 1 3.90e-4 8.52e-4 ✓ sig.
Amyloid neuropathy Early onset alzheimers disease with behavioral disturbance 0.200 1 3.90e-4 8.52e-4 ✓ sig.
Acne inversa Amyloid neuropathy 0.167 1 5.84e-4 1.14e-3 ✓ sig.